International Symposium on Malignant Mesothelioma 2017 (Day 2)
The 2017 International Symposium on Malignant Mesothelioma is the only conference of its kind to bring together scientists and patients alike. It covers topics such as mesothelioma science, treatment options, including clinical trials, immunotherapy, surgery, and pain management among many others. This conference is geared to attendees from all walks of life, including patients and their families, advocates, medical professionals, those who have lost loved ones to mesothelioma, and scientists.For more information go tohttp://www.curemeso.org/site/c.duIWJfNQKiL8G/b.8598593/k.D685/Homepage.htmAir date: 3/28/2017 9:00:00 AM (...
Source: Videocast - All Events - March 16, 2017 Category: Journals (General) Tags: Upcoming Events Source Type: video
International Symposium on Malignant Mesothelioma 2017 (Day 1)
The 2017 International Symposium on Malignant Mesothelioma is the only conference of its kind to bring together scientists and patients alike. It covers topics such as mesothelioma science, treatment options, including clinical trials, immunotherapy, surgery, and pain management among many others. This conference is geared to attendees from all walks of life, including patients and their families, advocates, medical professionals, those who have lost loved ones to mesothelioma, and scientists.For more information go tohttp://www.curemeso.org/site/c.duIWJfNQKiL8G/b.8598593/k.D685/Homepage.htmAir date: 3/27/2017 9:00:00 AM (...
Source: Videocast - All Events - March 16, 2017 Category: Journals (General) Tags: Upcoming Events Source Type: video
Demystifying Medicine 2017: Immunotherapy of Cancer
The Demystifying Medicine Lecture Series is designed to help bridge the gap between advances in biology and their applications to major human diseases. Each lecture will feature a presentation on a major disease, including current research and advancements on treatments.For more information go tohttps://demystifyingmedicine.od.nih.gov/Air date: 5/16/2017 4:00:00 PM (Source: Videocast - All Events)
Source: Videocast - All Events - January 24, 2017 Category: Journals (General) Tags: Upcoming Events Source Type: video
Is the Right Flavor of Inflammation the Key to Successful Cancer Therapy?
NCI ’ s Center for Cancer Research (CCR) Grand Rounds
Dr. Romina Goldszmid received her Ph.D. working on dendritic cell-based vaccines for melanoma immunotherapy from the University of Buenos Aires, Argentina, part of which was performed as a visiting scholar in the laboratory of Dr. Ralph Steinman at the Rockefeller University. She then did her postdoctoral training in infectious diseases immunology with Dr. Alan Sher in the Laboratory of Parasitic Diseases (LPD) at NIAID. There, Dr. Goldszmid focused on the interplay between dendritic cells and natural killer cells during the early response to Toxoplasma gondii infecti...
Source: Videocast - All Events - January 23, 2017 Category: Journals (General) Tags: Upcoming Events Source Type: video
Daniel J. DeAngelo, MD, PhD - Treatment Evolution in Acute Lymphoblastic Leukemia: Insight on Novel Antibody Technologies and Immunotherapy Advances
Treatment Evolution in Acute Lymphoblastic Leukemia: Insight on Novel Antibody Technologies and Immunotherapy Advances (Source: PeerView CME/CE Video Podcast - Oncology)
Source: PeerView CME/CE Video Podcast - Oncology - January 9, 2017 Category: Cancer & Oncology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: video
Innate molecules in the inflammation and cancer
Wednesday Afternoon Lecture Series
Dr. Cao has been investigating the molecular mechanisms for innate immune response and inflammation, and trying new approaches to cancer immunotherapy. As corresponding author, he published 226 original papers in peer-reviewed journals including Cell, Nature, Science, Nature Immunology, Immunity, Cancer Cell.
Dr. Xuetao Cao is the current President of Chinese Academy of Medical Sciences and Peking Union Medical College.
Dr. Cao ’ s laboratory focuses on the understanding of innate signaling in immunity and inflammation, identification of cell subsets and new molecules in dendritic cell ...
Source: Videocast - All Events - November 7, 2016 Category: Journals (General) Tags: Upcoming Events Source Type: video
Stressed out: a novel approach to cancer immunotherapy
NIH Director's Wednesday Afternoon Lecture
Inaugural William Paul Lecture
Dr. Glimcher is president and CEO of Dana-Farber Cancer Institute in Boston and a former dean of Weill Cornell Medical College in New York City. Prior to her work at Cornell, Dr. Glimcher was a professor of medicine at Harvard Medical School, where she headed one of the top immunology programs in the world. As an immunologist, her primary research interests are elucidating the molecular pathways that regulate the immune system, critical for both the development of protective immunity and for the pathophysiologic immune responses underlying autoimmune...
Source: Videocast - All Events - November 7, 2016 Category: Journals (General) Tags: Upcoming Events Source Type: video
Transforming Pancreatic Cancer into an Immunological Disease
NCI ’ s Center for Cancer Research (CCR) Grand Rounds
Dr. Jaffee currently serves as Deputy Director for the Sidney Kimmel Comprehensive Cancer Center (SKCCC) at Johns Hopkins University (JHU), and Co-Director of the Immunology Program and Associate Director for Translational Sciences for SKCCC. She established the Cell and Gene Therapy Processing Facility (cGMP facility) at JHU. In 2007, she was appointed Deputy Director for the Institute for Translational and Clinical Research at JHU School of Medicine. She has also served as Chair of the Clinical Research Committee at SKCCC.
Dr. Jaffee has served on a number of commit...
Source: Videocast - All Events - October 3, 2016 Category: Journals (General) Tags: Upcoming Events Source Type: video
NIH Research Festival Plenary Session III - Cell-based immune therapies
Cell-based immune therapies, such as immunotherapy for cancer, are among the hottest topics in clinical research. A centuries-old concept of stimulating the immune system to fight a non-infectious disease, immunotherapy became a viable treatment that doctors could exert some degree of control over as a result of pioneering research at the NCI in the 1960s and 1970s on monoclonal antibodies (Michael Potter) and Interleukin-2 (Robert Gallo). Building on such advances, NCI ’ s Steven Rosenberg, M.D., Ph.D. was the first to recognize the potential of Il-2 and apply it as a novel anti-cancer agent, in 1984. Rosenberg has spen...
Source: Videocast - All Events - September 12, 2016 Category: Journals (General) Tags: Upcoming Events Source Type: video
New Insights into Flavivirus Pathogenesis and Immunity: Yes, that Includes Zika Virus.
Dr. Michael Diamond received a B.A. degree in political science at Columbia University before pursuing medical and graduate training at Harvard School of Medicine. As a graduate student, he investigated the regulation of the integrin Mac-1 (CD11b/CD18) in the laboratory of Dr. Timothy Springer. He did a residency and a clinical fellowship in infectious diseases at the University of California, San Francisco, and most of his post-doctoral training in the laboratory of Dr. Eva Harris at the University of California, Berkeley. He was recruited to Washington University in St. Louis as an Assistant Professor in 2001 and is now ...
Source: Videocast - All Events - May 20, 2016 Category: Journals (General) Tags: Upcoming Events Source Type: video
Immune Modulation Therapy and Imaging: What can we do in clinical trials now?
Immunotherapy is rapidly becoming a successful strategy in treating malignancies. NCI is investing a large percentage of its resources to evaluate the role of various immunotherapies – either alone or in combination with other cytotoxic or cytostatic therapies. Assessment of tumor response with anatomic imaging and with the standard RECIST criteria has not been very helpful in patients receiving immunotherapy. Therefore, the Cancer Imaging Program is actively pursuing alternative methods of tumor response assessment in this setting. The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is partnering with CIP to ...
Source: Videocast - All Events - April 28, 2016 Category: Journals (General) Tags: Upcoming Events Source Type: video
Barbara Ann Burtness, MD - Is There a Future for Immunotherapy in Head and Neck Cancer?
Is There a Future for Immunotherapy in Head and Neck Cancer? (Source: PeerView CME/CE Video Podcast - Oncology)
Source: PeerView CME/CE Video Podcast - Oncology - April 22, 2016 Category: Cancer & Oncology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: video
Immunotherapy Biomarkers 2016: Overcoming the Barriers
Presented by: The Center for Cancer Research at the NCI, NIH and the Society for the Immunotherapy of CancerCategory: HHS OnlyAired date: 04/01/2016 (Source: Videocast - All Events)
Source: Videocast - All Events - April 5, 2016 Category: Journals (General) Tags: Past Events Source Type: video
The Role of PTPN22 in Autoimmunity and Viral Immunity.
Dr. Linda Sherman received her Ph.D. from M.I.T. in Biology, and did postdoctoral research in immunology at Albert Einstein Medical College and Harvard Medical School, after which she started her laboratory at The Scripps Research Institute, where she remained throughout her career. She has served on advisory panels for the National Science Foundation, The American Cancer Society, The Juvenile Diabetes Foundation, and The National Institutes of Health. She was a member of the Advisory Council to the National Institute of Diabetes and Digestive and Kidney Disease from 2002-2006. She has served on numerous committees for t...
Source: Videocast - All Events - March 24, 2016 Category: Journals (General) Tags: Upcoming Events Source Type: video
Challenges and Opportunities for Immunotherapy in Prostate Cancer
Presented by: James L. Gulley, M.D., Ph.D., Chief, Genitourinary Malignancies Branch, Director, Medical Oncology Service, Center for Cancer Research, NCI, NIH
Category: NCI CCR Grand Rounds (HHS Only)Aired date: 03/11/2016 (Source: Videocast - All Events)
Source: Videocast - All Events - March 14, 2016 Category: Journals (General) Tags: Past Events Source Type: video
